Biotech
Companies in the biotech (biotechnology) space manufacture drugs, therapies, vaccines, and medical diagnostic tests for the treatment of health disorders and illnesses. Demand for biotechnology in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. The industry is considered one of the riskiest for investors as drug development success is a difficult and costly process.
Share This Page
Industry Rating
Loading, please wait...
Rk | Symbol | Name | Last | Day
Chg
| Mkt
Cap
| POWR
|
|---|---|---|---|---|---|---|
| 1 | GILD | Gilead Sciences Inc. | 111.91 | 0.75 (0.67%) | 139.37B | A |
| 2 | JAZZ | Jazz Pharmaceuticals plc - Ordinary Shares | 124.06 | -2.34 (-1.85%) | 7.53B | A |
| 3 | ALKS | Alkermes plc - Ordinary Shares | 33.29 | -0.24 (-0.72%) | 5.41B | A |
| 4 | SBHMY | Sino Biopharmaceutical Limited | 9.38 | 0.43 (4.80%) | N/A | A |
| 5 | UCBJY | UCB SA | 89.01 | -0.60 (-0.67%) | 33.65B | A |
| 6 | OTSKY | Otsuka Holdings Co Ltd | 26.57 | 0.22 (0.84%) | N/A | A |
| 7 | PLX | Protalix BioTherapeutics, Inc. (DE) | 2.59 | 0.01 (0.39%) | 202.11M | A |
| 8 | EXEL | Exelixis, Inc. | 36.52 | -0.32 (-0.87%) | 10.22B | A |
| 9 | ORGO | Organogenesis Holdings Inc. | 4.56 | -0.11 (-2.36%) | 578.34M | A |
| 10 | SGIOY | Shionogi & Co., Ltd. | 7.65 | -0.01 (-0.13%) | 13.02B | A |
| 11 | BMRN | BioMarin Pharmaceutical Inc | 71.73 | -1.10 (-1.51%) | 13.68B | A |
| 12 | NPPNY | Nippon Shinyaku Co., Ltd. | 6.63 | -0.12 (-1.78%) | N/A | B |
| 13 | AMGN | Amgen Inc. | 307.32 | 1.55 (0.51%) | 165.09B | B |
| 14 | FOLD | Amicus Therapeutics, Inc. | 8.41 | -0.18 (-2.10%) | 2.58B | B |
| 15 | PBYI | Puma Biotechnology Inc | 3.15 | 0.00 (0.00%) | 156.27M | B |
| 16 | UTHR | United Therapeutics Corporation | 306.20 | -1.82 (-0.59%) | 13.75B | B |
| 17 | MKKGY | Merck KGaA | 28.19 | 0.44 (1.59%) | 18.22B | B |
| 18 | HRMY | Harmony Biosciences Holdings Inc. | 33.14 | -0.21 (-0.63%) | 1.90B | B |
| 19 | REGN | Regeneron Pharmaceuticals Inc. | 642.41 | 6.58 (1.03%) | 70.23B | B |
| 20 | GMAB | Genmab A/S ADR | 19.86 | -0.28 (-1.39%) | 13.14B | B |
| 21 | INCY | Incyte Corp. | 60.62 | -0.06 (-0.10%) | 11.73B | B |
| 22 | BIIB | Biogen Inc. | 139.31 | -1.02 (-0.73%) | 20.39B | B |
| 23 | LJPC | La Jolla Pharmaceutical Company | 6.22 | 0.00 (0.00%) | 155.11M | NR |
| 24 | HALO | Halozyme Therapeutics, Inc. | 63.60 | -0.88 (-1.36%) | 7.86B | B |
| 25 | GLUE | Monte Rosa Therapeutics, Inc. | 5.11 | -0.15 (-2.85%) | 314.32M | B |
| 26 | ILMN | Illumina Inc. | 79.78 | -2.50 (-3.04%) | 12.64B | B |
| 27 | BCRX | BioCryst Pharmaceuticals, Inc. | 7.86 | 0.03 (0.38%) | 1.64B | B |
| 28 | THTX | Theratechnologies, Inc. | 1.53 | -0.15 (-8.68%) | 70.12M | B |
| 29 | CSBR | Champions Oncology, Inc. | 9.37 | -0.13 (-1.37%) | 129.56M | B |
| 30 | ADAP | Adaptimmune Therapeutics plc | 0.21 | -0.01 (-5.45%) | 53.22M | B |
| 31 | ANIK | Anika Therapeutics Inc. | 15.28 | -0.22 (-1.42%) | 216.61M | B |
| 32 | ACOR | Acorda Therapeutics, Inc. | 0.66 | -0.22 (-24.86%) | 820.96K | NR |
| 33 | TRDA | Entrada Therapeutics, Inc. | 9.69 | -0.27 (-2.71%) | 364.30M | B |
| 34 | EQ | Equillium, Inc. | 0.40 | -0.09 (-18.03%) | 14.17M | B |
| 35 | GOSS | Gossamer Bio, Inc. | 1.16 | 0.00 (0.00%) | 263.58M | B |
| 36 | TAIPY | Taisho Pharmaceutical Holdings Company Ltd. | 14.00 | 2.00 (16.67%) | N/A | B |
| 37 | MNKD | MannKind Corporation | 5.04 | -0.06 (-1.18%) | 1.53B | B |
| 38 | DVAX | Dynavax Technologies Corporation | 13.70 | -0.02 (-0.15%) | 1.70B | B |
| 39 | GNFT | GENFIT S.A. | 3.67 | 0.12 (3.38%) | 183.49M | NR |
| 40 | AVEO | AVEO Pharmaceuticals, Inc. | 15.00 | 0.00 (0.00%) | 521.45M | NR |
| 41 | VRTX | Vertex Pharmaceuticals Inc. | 496.79 | -5.76 (-1.15%) | 127.57B | B |
| 42 | INVA | Innoviva, Inc. | 18.33 | 0.45 (2.52%) | 1.15B | B |
| 43 | DCPH | Deciphera Pharmaceuticals, Inc. | 25.59 | 0.02 (0.08%) | 2.21B | C |
| 44 | KURA | Kura Oncology, Inc. | 7.01 | -0.13 (-1.82%) | 566.09M | C |
| 45 | JNCE | Jounce Therapeutics, Inc. | 1.88 | -0.05 (-2.59%) | 98.95M | NR |
| 46 | TECH | Bio-Techne Corp | 58.92 | -1.03 (-1.72%) | 9.31B | C |
| 47 | TCON | TRACON Pharmaceuticals, Inc. | 0.03 | -0.01 (-25.98%) | 109.74K | C |
| 48 | ICPT | Intercept Pharmaceuticals, Inc. | 19.00 | 0.04 (0.21%) | 793.88M | NR |
| 49 | SIGA | SIGA Technologies Inc. | 5.45 | -0.12 (-2.15%) | 389.33M | C |
| 50 | IMCR | Immunocore Holdings plc | 29.50 | -0.63 (-2.09%) | 1.48B | C |
| 51 | BDSI | BioDelivery Sciences International, Inc. | 5.59 | -0.01 (-0.18%) | 577.05M | NR |
| 52 | AYTU | Aytu BioScience, Inc. | 1.21 | -0.04 (-2.82%) | 7.43M | C |
| 53 | TBPH | Theravance Biopharma, Inc. - Ordinary Shares | 9.25 | -0.06 (-0.64%) | 457.61M | C |
| 54 | BNTX | BioNTech SE ADR | 94.40 | -1.00 (-1.05%) | 22.65B | C |
| 55 | VNDA | Vanda Pharmaceuticals Inc. | 4.69 | 0.09 (1.96%) | 273.50M | C |
| 56 | CRIS | Curis, Inc. | 2.41 | 0.00 (0.00%) | 20.41M | C |
| 57 | PRTK | Paratek Pharmaceuticals, Inc. | 2.23 | 0.04 (1.83%) | 127.83M | NR |
| 58 | KRYS | Krystal Biotech, Inc. | 183.54 | 0.79 (0.43%) | 5.29B | C |
| 59 | ARGX | arGEN-X SE ADR | 591.64 | -1.83 (-0.31%) | 35.95B | C |
| 60 | XLO | Xilio Therapeutics, Inc. | 0.71 | -0.02 (-2.73%) | 36.76M | C |
| 61 | FGEN | FibroGen, Inc | 0.31 | -0.02 (-6.95%) | 30.80M | C |
| 62 | VXRT | Vaxart Inc. | 0.43 | -0.03 (-5.67%) | 98.27M | C |
| 63 | CORT | Corcept Therapeutics Incorporated | 54.21 | -2.47 (-4.36%) | 5.72B | C |
| 64 | ALNY | Alnylam Pharmaceuticals Inc. | 268.84 | -2.18 (-0.80%) | 34.97B | C |
| 65 | SRPT | Sarepta Therapeutics, Inc. | 70.57 | -1.24 (-1.73%) | 6.85B | C |
| 66 | MOLN | MOLECULAR PARTNERS AG | 4.50 | 0.20 (4.65%) | 181.69M | NR |
| 67 | SOLCF | SOL Global Investments Corp. | 0.06 | -0.01 (-18.70%) | N/A | NR |
| 68 | FULC | Fulcrum Therapeutics, Inc. | 3.00 | -0.09 (-2.91%) | 161.94M | C |
| 69 | BLPH | Bellerophon Therapeutics, Inc. | 0.01 | -0.00 (-25.47%) | 146.80K | NR |
| 70 | HRTX | Heron Therapeutics, Inc. | 2.24 | -0.07 (-3.03%) | 341.22M | C |
| 71 | RPRX | Royalty Pharma PLC | 31.25 | -0.40 (-1.26%) | 18.01B | C |
| 72 | ALLK | Allakos Inc. | 0.23 | -0.00 (-1.96%) | 20.76M | C |
| 73 | CVAC | CureVac N.V | 3.03 | 0.23 (8.21%) | 678.36M | C |
| 74 | NKTR | Nektar Therapeutics | 0.75 | -0.01 (-0.67%) | 140.08M | C |
| 75 | CSLLY | CSL Ltd. ADR | 79.00 | -0.37 (-0.47%) | 76.51B | C |
| 76 | RGNX | REGENXBIO Inc. | 7.93 | 0.02 (0.25%) | 397.18M | C |
| 77 | ASND | Ascendis Pharma A/S | 154.38 | -3.56 (-2.25%) | 9.37B | C |
| 78 | VACC | Vaccitech plc | 5.00 | 0.51 (11.36%) | 192.74M | NR |
| 79 | ESPR | Esperion Therapeutics, Inc. | 1.53 | -0.09 (-5.28%) | 301.72M | C |
| 80 | INFI | Infinity Pharmaceuticals, Inc. | 0.01 | -0.01 (-50.00%) | 719.28K | NR |
| 81 | IPSC | Century Therapeutics, Inc. | 0.53 | -0.02 (-3.90%) | 45.35M | C |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 37.92 | -0.97 (-2.49%) | 3.51B | C |
| 83 | PSTV | PLUS THERAPEUTICS, Inc. | 1.16 | -0.36 (-23.61%) | 6.85M | C |
| 84 | SELB | Selecta Biosciences, Inc. | 0.88 | -0.08 (-8.00%) | 136.77M | NR |
| 85 | PMCB | PharmaCyte Biotech Inc. | 1.35 | -0.03 (-2.10%) | 9.27M | NR |
| 86 | FHTX | Foghorn Therapeutics, Inc. | 3.65 | -0.23 (-5.93%) | 202.98M | C |
| 87 | IMGN | ImmunoGen, Inc. | 31.23 | 0.00 (0.00%) | 8.32B | NR |
| 88 | GRPH | Graphite Bio, Inc. | 3.18 | -0.09 (-2.75%) | 185.19M | C |
| 89 | KRON | Kronos Bio Inc. | 0.84 | 0.01 (1.48%) | 51.04M | C |
| 90 | MIRO | Miromatrix Medical Inc. | 3.39 | 0.02 (0.59%) | 92.95M | NR |
| 91 | RCUS | Arcus Biosciences, Inc. | 8.20 | -0.29 (-3.42%) | 862.13M | C |
| 92 | BGNE | BeiGene Ltd. ADR | 184.71 | 0.90 (0.49%) | 18.03B | C |
| 93 | NXTC | NextCure, Inc. | 0.51 | -0.02 (-4.09%) | 14.26M | C |
| 94 | VCYT | Veracyte, Inc. | 29.82 | -1.28 (-4.12%) | 2.32B | C |
| 95 | ADMA | ADMA Biologics Inc | 20.13 | -0.15 (-0.74%) | 4.76B | C |
| 96 | STOK | Stoke Therapeutics Inc. | 7.21 | -0.24 (-3.22%) | 389.90M | C |
| 97 | SEEL | Seelos Therapeutics, Inc. | 0.39 | -0.15 (-27.79%) | 145.08K | C |
| 98 | LVTX | LAVA Therapeutics BV | 1.28 | -0.02 (-1.54%) | 33.66M | C |
| 99 | IMRA | Imara Inc. | 6.32 | 0.87 (15.96%) | 165.80M | NR |
| 100 | GTHX | G1 Therapeutics, Inc. | 7.15 | 0.00 (0.00%) | 373.81M | C |
| 101 | EBS | Emergent Biosolutions, Inc. | 4.61 | -0.32 (-6.40%) | 250.49M | C |
| 102 | ANGN | Angion Biomedica Corp | 1.00 | 0.02 (2.04%) | 30.11M | NR |
| 103 | BOLT | Bolt Biotherapeutics, Inc. | 0.43 | -0.01 (-1.93%) | 16.52M | C |
| 104 | CALA | Calithera Biosciences, Inc. | 0.00 | 0.00 (500.00%) | 2.92K | NR |
| 105 | ALVR | AlloVir Inc. | 9.81 | 0.15 (1.55%) | 49.47M | C |
| 106 | KZR | Kezar Life Sciences, Inc. | 5.03 | -0.10 (-1.95%) | 36.75M | C |
| 107 | PASG | Passage Bio Inc. | 0.38 | -0.03 (-8.03%) | 23.62M | C |
| 108 | SGMO | Sangamo Therapeutics, Inc. | 0.83 | -0.03 (-3.11%) | 186.64M | C |
| 109 | CYT | Cyteir Therapeutics, Inc. | 3.02 | -0.07 (-2.27%) | 108.71M | C |
| 110 | CDAK | Codiak BioSciences Inc. | 0.06 | -0.07 (-55.98%) | 2.10M | NR |
| 111 | RPHM | Reneo Pharmaceuticals, Inc. | 1.82 | 0.09 (5.20%) | 60.83M | C |
| 112 | TGTX | TG Therapeutics, Inc. | 39.09 | -1.11 (-2.76%) | 6.14B | C |
| 113 | NVAX | Novavax, Inc. | 7.02 | -0.24 (-3.34%) | 1.13B | C |
| 114 | ARDX | Ardelyx, Inc. | 5.03 | -0.11 (-2.04%) | 1.20B | C |
| 115 | PTCT | PTC Therapeutics, Inc. | 53.54 | -1.45 (-2.64%) | 4.22B | C |
| 116 | ATRA | Atara Biotherapeutics, Inc. | 6.55 | -0.33 (-4.72%) | 38.38M | C |
| 117 | ENTA | Enanta Pharmaceuticals, Inc. | 5.69 | -0.17 (-2.90%) | 121.38M | C |
| 118 | SESN | Sesen Bio, Inc. | 0.63 | 0.04 (7.29%) | 127.96M | NR |
| 119 | HARP | Harpoon Therapeutics, Inc. | 23.01 | 0.02 (0.09%) | 389.61M | NR |
| 120 | ASLN | ASLAN Pharmaceuticals Limited | 0.60 | -0.10 (-14.27%) | 1.23M | C |
| 121 | ADPT | Adaptive Biotechnologies Corporation | 7.60 | -0.62 (-7.54%) | 1.13B | C |
| 122 | ANAB | AnaptysBio, Inc. | 19.03 | 0.39 (2.06%) | 583.59M | C |
| 123 | PRTA | Prothena Corporation plc - Ordinary Shares | 13.06 | 0.05 (0.38%) | 702.98M | C |
| 124 | NBSE | NeuBase Therapeutics, Inc. | 0.38 | -0.01 (-3.20%) | 1.42M | NR |
| 125 | ITCI | Intra-Cellular Therapies Inc. | 131.82 | 0.07 (0.05%) | 14.04B | C |
| 126 | LEGN | Legend Biotech Corp. ADR | 35.11 | -0.28 (-0.79%) | 6.45B | C |
| 127 | MRKR | Marker Therapeutics, Inc. | 1.31 | -0.06 (-4.38%) | 14.03M | C |
| 128 | ONCT | Oncternal Therapeutics, Inc. | 0.53 | -0.17 (-24.11%) | 1.56M | C |
| 129 | CGEN | Compugen Ltd. - Ordinary Shares | 1.53 | 0.01 (0.66%) | 136.53M | C |
| 130 | CERS | Cerus Corporation | 1.42 | -0.02 (-1.39%) | 263.82M | C |
| 131 | IPHA | INNATE PHARMA SA | 1.98 | 0.01 (0.51%) | 165.98M | NR |
| 132 | CINC | CinCor Pharma, Inc., | 29.06 | -0.14 (-0.48%) | 1.27B | NR |
| 133 | MGNX | MacroGenics, Inc. | 1.37 | -0.12 (-7.77%) | 86.12M | C |
| 134 | SQZ | SQZ Biotechnologies Co. | 0.44 | 0.17 (61.11%) | 12.83M | NR |
| 135 | EPZM | Epizyme, Inc. | 1.47 | -0.02 (-1.34%) | 247.44M | NR |
| 136 | OBSV | ObsEva SA | 0.10 | -0.02 (-15.52%) | 7.94M | NR |
| 137 | APOP | Cellect Biotechnology Ltd. | 13.17 | 0.05 (0.38%) | 12.87M | NR |
| 138 | AGEN | Agenus Inc. | 1.61 | -0.06 (-3.31%) | 40.62M | C |
| 139 | PCSA | Processa Pharmaceuticals, Inc. | 0.38 | -0.01 (-2.49%) | 1.24M | C |
| 140 | CTIC | CTI BioPharma Corp. | 9.09 | 0.00 (0.00%) | 1.20B | NR |
| 141 | HCWB | HCW Biologics Inc. | 0.29 | -0.01 (-2.71%) | 13.11M | NR |
| 142 | QLI | Qilian International Holding Group Limited | 5.41 | -0.35 (-6.08%) | 38.68M | NR |
| 143 | KMPH | KemPharm, Inc. | 5.81 | -0.02 (-0.34%) | 200.47M | NR |
| 144 | CASI | CASI Pharmaceuticals, Inc. | 2.15 | -0.05 (-2.27%) | 33.31M | C |
| 145 | SNSE | Sensei Biotherapeutics, Inc. | 0.56 | 0.13 (29.81%) | 14.06M | C |
| 146 | ATHE | Alterity Therapeutics Limited | 3.50 | 0.00 (0.00%) | 31.03M | C |
| 147 | EVAX | Evaxion Biotech A/S | 1.69 | -0.07 (-3.98%) | 1.98M | C |
| 148 | CNTB | Connect Biopharma Holdings Limited | 0.75 | -0.01 (-1.32%) | 41.44M | C |
| 149 | KNTE | Kinnate Biopharma | 2.65 | -0.01 (-0.38%) | 125.15M | C |
| 150 | TSVT | 2seventy bio Inc. | 4.95 | 0.00 (0.00%) | 255.36M | C |
| 151 | DTIL | Precision BioSciences, Inc. | 4.62 | 0.08 (1.76%) | 35.44M | C |
| 152 | PNT | POINT Biopharma Global Inc., | 12.50 | 0.02 (0.16%) | 1.33B | NR |
| 153 | SGEN | Seagen Inc. | 228.74 | -0.16 (-0.07%) | 42.93B | NR |
| 154 | THRX | Theseus Pharmaceuticals, Inc. | 4.06 | 0.00 (0.00%) | 179.57M | C |
| 155 | OCUP | Ocuphire Pharma Inc. | 1.17 | -0.16 (-12.03%) | 30.33M | C |
| 156 | STSA | SATSUMA PHARMACEUTICALS, INC. | 1.10 | -0.01 (-0.90%) | 36.47M | NR |
| 157 | OTIC | Otonomy, Inc. | 0.01 | -0.11 (-92.64%) | 582.48K | NR |
| 158 | NLTX | Neoleukin Therapeutics, Inc. | 3.49 | 0.05 (1.45%) | 32.80M | NR |
| 159 | CYCN | Cyclerion Therapeutics, Inc. | 2.46 | -0.15 (-5.75%) | 6.67M | C |
| 160 | RNXT | RenovoRx, Inc. | 1.01 | -0.01 (-0.98%) | 24.24M | NR |
| 161 | RVNC | Revance Therapeutics, Inc. | 3.65 | 0.01 (0.27%) | 381.02M | C |
| 162 | CLVS | Clovis Oncology, Inc. | 0.08 | -0.00 (-5.58%) | 11.77M | NR |
| 163 | BDTX | Black Diamond Therapeutics Inc. | 1.61 | -0.07 (-3.89%) | 90.94M | C |
| 164 | AVRO | AVROBIO, Inc. | 1.40 | -0.02 (-1.41%) | 62.85M | C |
| 165 | BCAB | BioAtla, Inc. | 0.35 | -0.05 (-11.84%) | 16.73M | C |
| 166 | GBT | Global Blood Therapeutics, Inc. | 68.49 | 0.01 (0.01%) | 4.62B | NR |
| 167 | ALEC | Alector, Inc. | 1.30 | -0.03 (-2.26%) | 128.81M | C |
| 168 | ENLV | Enlivex Therapeutics Ltd. | 1.00 | -0.01 (-0.59%) | 21.49M | C |
| 169 | URGN | UroGen Pharma Ltd. - Ordinary Shares | 11.22 | -0.23 (-2.01%) | 517.17M | C |
| 170 | LUMO | Lumos Pharma, Inc. | 4.34 | 0.00 (0.00%) | 37.54M | C |
| 171 | GRTX | GALERA THERAPEUTICS, INC. | 0.03 | -0.00 (-1.52%) | 1.77M | NR |
| 172 | DMAC | DiaMedica Therapeutics Inc. | 3.92 | -0.22 (-5.31%) | 168.00M | C |
| 173 | IMTX | Immatics N.V. | 4.60 | -0.11 (-2.34%) | 549.04M | C |
| 174 | NBY | NovaBay Pharmaceuticals, Inc. | 0.61 | 0.00 (0.02%) | 3.54M | C |
| 175 | HSTO | Histogen Inc. | 0.22 | 0.00 (0.00%) | 918.05K | NR |
| 176 | BCEL | Atreca, Inc. - | 0.09 | -0.00 (-1.32%) | 3.57M | NR |
| 177 | LIAN | LianBio | 0.32 | -0.03 (-8.28%) | 34.47M | C |
| 178 | VALN | Valneva SE | 7.17 | -0.08 (-1.10%) | 582.64M | C |
| 179 | DRNA | Dicerna Pharmaceuticals, Inc. | 38.22 | 0.22 (0.58%) | 2.99B | NR |
| 180 | CRMD | CorMedix Inc. | 6.55 | -0.16 (-2.46%) | 426.94M | C |
| 181 | VSTM | Verastem, Inc. | 6.32 | -0.41 (-6.09%) | 325.40M | C |
| 182 | ARQT | Arcutis Biotherapeutics Inc. | 15.60 | -0.49 (-3.05%) | 1.85B | C |
| 183 | ANEB | Anebulo Pharmaceuticals, Inc. | 1.25 | -0.15 (-10.71%) | 51.36M | NR |
| 184 | ADCT | ADC Therapeutics S.A. | 1.47 | -0.05 (-3.29%) | 142.13M | C |
| 185 | PSTI | Pluristem Therapeutics, Inc. | 1.00 | -0.03 (-2.91%) | 32.35M | NR |
| 186 | CCXI | ChemoCentryx, Inc. | 51.99 | 0.03 (0.06%) | 3.71B | NR |
| 187 | DAWN | Day One Biopharmaceuticals, Inc. | 7.96 | -0.23 (-2.81%) | 806.79M | C |
| 188 | CHRS | Coherus BioSciences, Inc. | 0.84 | -0.01 (-1.02%) | 97.62M | C |
| 189 | SPPI | Spectrum Pharmaceuticals, Inc. | 1.03 | 0.00 (0.00%) | 211.40M | NR |
| 190 | VIR | VIR BIOTECHNOLOGY, INC. | 6.63 | -0.04 (-0.60%) | 909.26M | C |
| 191 | BBI | Brickell Biotech, Inc. | 2.35 | 0.05 (2.17%) | 6.75M | NR |
| 192 | ZYME | Zymeworks Inc. Common Shares | 12.27 | -0.24 (-1.88%) | 853.71M | C |
| 193 | VCEL | Vericel Corporation | 44.14 | -1.93 (-4.19%) | 2.21B | C |
| 194 | FRLN | Freeline Therapeutics Holdings PLC ADR | 6.48 | 0.00 (0.00%) | 28.13M | C |
| 195 | BDSX | Biodesix Inc. | 0.68 | -0.03 (-4.63%) | 99.24M | C |
| 196 | GLPG | Galapagos NV | 25.28 | -0.22 (-0.86%) | 1.67B | C |
| 197 | CLSN | Celsion Corporation | 1.96 | 0.00 (0.00%) | 13.91M | NR |
| 198 | ARAV | Aravive, Inc. | 0.04 | -0.01 (-13.39%) | 2.95M | NR |
| 199 | TVTX | Travere Therapeutics, Inc. | 19.51 | -0.86 (-4.20%) | 1.73B | C |
| 200 | CERT | Certara Inc. | 9.77 | -0.35 (-3.46%) | 1.57B | C |
| 201 | VOR | Vor Biopharma Inc. | 0.77 | 0.00 (0.29%) | 52.74M | C |
| 202 | GMTX | Gemini Therapeutics, Inc. | 1.35 | 0.00 (0.00%) | 58.49M | NR |
| 203 | TARA | Protara Therapeutics, Inc. | 4.47 | -0.07 (-1.54%) | 164.35M | C |
| 204 | VECT | VectivBio Holding AG | 16.85 | 0.00 (0.00%) | 573.24M | NR |
| 205 | SGTX | Sigilon Therapeutics Inc. | 22.47 | -0.59 (-2.56%) | 56.49M | NR |
| 206 | SCPS | Scopus Biopharma Inc. | 0.00 | 0.00 (0.00%) | 12.63K | NR |
| 207 | PIRS | Pieris Pharmaceuticals, Inc. | 13.60 | -2.53 (-15.69%) | 17.95M | C |
| 208 | ZNTL | Zentalis Pharmaceuticals Inc. | 1.75 | -0.04 (-2.23%) | 124.71M | C |
| 209 | MITO | Stealth BioTherapeutics Corp. - ADS | 0.32 | -0.00 (-1.36%) | 23.54M | NR |
| 210 | CYTR | CytRx Corporation | 0.09 | 0.00 (0.00%) | 4.14M | NR |
| 211 | TLGT | Teligent, Inc. | 0.17 | -0.03 (-13.85%) | 16.10M | NR |
| 212 | GHRS | GH Research PLC | 11.49 | -0.76 (-6.16%) | 597.80M | C |
| 213 | FNCH | Finch Therapeutics Group, Inc., | 14.30 | 0.00 (0.00%) | 22.97M | NR |
| 214 | ERAS | Erasca, Inc. | 1.53 | -0.03 (-1.61%) | 431.98M | C |
| 215 | TALS | Talaris Therapeutics, Inc. | 2.72 | -0.02 (-0.73%) | 116.32M | NR |
| 216 | TIL | Instil Bio, Inc. | 18.23 | -1.13 (-5.84%) | 118.97M | C |
| 217 | SPRB | Spruce Biosciences Inc. | 0.29 | -0.03 (-8.47%) | 12.00M | C |
| 218 | SRZN | Surrozen, Inc | 10.75 | -0.64 (-5.62%) | 34.94M | C |
| 219 | DBVT | DBV Technologies S.A. | 5.71 | 1.80 (46.04%) | 117.45M | C |
| 220 | LYEL | Lyell Immunopharma, Inc. | 0.54 | -0.05 (-8.64%) | 160.10M | C |
| 221 | REPH | Recro Pharma, Inc. | 2.09 | -0.01 (-0.48%) | 117.93M | NR |
| 222 | DNA | Ginkgo Bioworks Holdings, Inc. | 6.16 | -0.43 (-6.54%) | 357.49M | C |
| 223 | ANTX | AN2 Therapeutics, Inc., | 1.43 | -0.01 (-0.69%) | 42.73M | C |
| 224 | SNSS | Sunesis Pharmaceuticals, Inc. | 5.32 | 1.04 (24.30%) | 96.25M | NR |
| 225 | MACK | Merrimack Pharmaceuticals, Inc. | 15.13 | 0.00 (0.00%) | 223.74M | C |
| 226 | CMRX | Chimerix, Inc. | 8.51 | 0.01 (0.06%) | 798.27M | C |
| 227 | AURA | Aura Biosciences, Inc. | 6.12 | 0.18 (3.06%) | 307.38M | C |
| 228 | PULM | Pulmatrix, Inc. | 7.14 | -0.08 (-1.11%) | 26.06M | C |
| 229 | MCRB | Seres Therapeutics, Inc. | 0.71 | -0.05 (-6.51%) | 123.10M | C |
| 230 | MNOV | MediciNova, Inc. | 1.45 | -0.05 (-3.33%) | 71.12M | NR |
| 231 | RUBY | Rubius Therapeutics, Inc. | 0.06 | 0.00 (2.70%) | 5.16M | NR |
| 232 | HGEN | Humanigen, Inc. | 0.00 | -0.00 (-84.62%) | 23.82K | NR |
| 233 | IKNA | Ikena Oncology, Inc. | 1.32 | -0.01 (-0.75%) | 63.70M | C |
| 234 | AWH | Aspira Women's Health Inc. | 0.10 | -0.01 (-5.45%) | 1.84M | C |
| 235 | ELYM | Eliem Therapeutics, Inc. | 5.11 | -0.05 (-0.97%) | 152.03M | C |
| 236 | GLS | Gelesis Holdings Inc., | 0.16 | 0.00 (0.38%) | 11.63M | NR |
| 237 | ATHX | Athersys, Inc. | 0.01 | -0.01 (-33.50%) | 833.21K | NR |
| 238 | PTE | PolarityTE, Inc. | 0.24 | -0.00 (-0.82%) | 1.78M | NR |
| 239 | BTX | Brooklyn ImmunoTherapeutics Inc. | 6.27 | -0.17 (-2.64%) | 368.84M | NR |
| 240 | AKBA | Akebia Therapeutics, Inc. | 1.90 | -0.03 (-1.55%) | 448.84M | C |
| 241 | LGND | Ligand Pharmaceuticals Incorporated | 108.36 | -1.34 (-1.22%) | 2.09B | C |
| 242 | SEER | Seer Inc. Cl A | 1.78 | -0.03 (-1.39%) | 106.11M | C |
| 243 | DFFN | Diffusion Pharmaceuticals Inc. | 4.40 | 0.46 (11.68%) | 8.98M | NR |
| 244 | ANIP | ANI Pharmaceuticals, Inc. | 67.80 | -0.56 (-0.82%) | 1.48B | C |
| 245 | VERV | Verve Therapeutics, Inc. | 5.22 | -0.06 (-1.14%) | 463.52M | C |
| 246 | NK | NantKwest, Inc. | 32.49 | 4.21 (14.89%) | 3.55B | NR |
| 247 | MDNA | Medicenna Therapeutics Corp. | 0.16 | -0.02 (-13.16%) | 10.93M | NR |
| 248 | TWST | Twist Bioscience Corporation | 39.81 | -1.78 (-4.27%) | 2.37B | C |
| 249 | TNGX | Tango Therapeutics, Inc. | 1.49 | -0.12 (-7.45%) | 161.08M | C |
| 250 | BNTC | Benitec Biopharma Inc. | 13.63 | -0.10 (-0.72%) | 319.64M | C |
| 251 | VRNA | Verona Pharma plc - American Depositary Share | 63.61 | -0.90 (-1.40%) | 5.14B | C |
| 252 | LCTX | Lineage Cell Therapeutics, Inc. | 0.49 | -0.01 (-1.91%) | 111.23M | C |
| 253 | ATHA | Athira Pharma Inc. | 0.30 | 0.00 (0.00%) | 11.75M | C |
| 254 | SRNE | Sorrento Therapeutics Inc. | 0.00 | 0.00 (0.00%) | 385.90K | NR |
| 255 | MRSN | Mersana Therapeutics, Inc. | 0.42 | 0.05 (12.36%) | 52.12M | C |
| 256 | BCLI | Brainstorm Cell Therapeutics Inc. | 1.20 | -0.16 (-11.48%) | 6.82M | C |
| 257 | AVIR | Atea Pharmaceuticals Inc. | 2.95 | -0.07 (-2.15%) | 252.30M | C |
| 258 | COYA | Coya Therapeutics Inc. | 6.63 | -0.26 (-3.77%) | 110.89M | D |
| 259 | AKUS | Akouos Inc. | 13.29 | 0.14 (1.06%) | 490.88M | NR |
| 260 | KIN | Kindred Biosciences, Inc. | 9.25 | 0.01 (0.11%) | 420.52M | NR |
| 261 | XOMA | XOMA Corporation | 20.80 | -0.17 (-0.81%) | 249.16M | D |
| 262 | ALGS | Aligos Therapeutics Inc. | 9.06 | -0.60 (-6.21%) | 55.39M | D |
| 263 | JAGX | Jaguar Health, Inc. | 5.14 | -0.24 (-4.37%) | 3.37M | D |
| 264 | MTNB | Matinas Biopharma Holdings, Inc. | 0.54 | -0.02 (-3.63%) | 2.77M | D |
| 265 | TELA | TELA BIO, INC. | 1.24 | -0.13 (-9.49%) | 48.84M | D |
| 266 | PRDS | Pardes Biosciences, Inc. | 2.16 | 0.00 (0.00%) | 133.95M | NR |
| 267 | NRBO | NeuroBo Pharmaceuticals Inc. | 2.36 | 0.01 (0.43%) | 20.33M | D |
| 268 | SBTX | Silverback Therapeutics Inc. | 5.87 | 0.06 (1.03%) | 211.66M | NR |
| 269 | TARS | Tarsus Pharmaceuticals Inc. | 51.15 | 0.50 (1.00%) | 1.96B | D |
| 270 | HLVX | HilleVax, Inc., | 1.61 | 0.00 (0.00%) | 80.19M | D |
| 271 | DARE | Daré Bioscience, Inc. | 2.92 | 0.03 (0.88%) | 25.40M | D |
| 272 | AMRN | Amarin Corp. PLC ADR | 0.46 | -0.01 (-2.55%) | 187.02M | D |
| 273 | ROIV | Roivant Sciences Ltd. | 10.32 | -0.15 (-1.48%) | 7.36B | D |
| 274 | XXII | 22nd Century Group, Inc. | 1.35 | -0.09 (-6.40%) | 3.19M | D |
| 275 | ONCS | OncoSec Medical Incorporated | 0.28 | 0.07 (31.87%) | 1.26M | NR |
| 276 | NERV | Minerva Neurosciences, Inc | 1.81 | -0.00 (-0.25%) | 12.63M | D |
| 277 | VIGL | Vigil Neuroscience, Inc., | 1.88 | -0.01 (-0.42%) | 87.84M | D |
| 278 | BPMC | Blueprint Medicines Corporation | 88.08 | -1.65 (-1.84%) | 5.63B | D |
| 279 | CANF | Can-Fite Biopharma Ltd Sponsored ADR (Israel) | 1.47 | -0.07 (-4.55%) | 5.20M | D |
| 280 | OVID | Ovid Therapeutics Inc. | 0.37 | -0.01 (-1.43%) | 26.55M | D |
| 281 | JANX | Janux Therapeutics, Inc. | 29.55 | -0.23 (-0.77%) | 1.75B | D |
| 282 | ADXS | Advaxis, Inc. | 0.05 | 0.02 (50.00%) | 1.92M | NR |
| 283 | ADAG | Adagene Inc. | 1.55 | -0.12 (-6.91%) | 73.02M | D |
| 284 | PYXS | Pyxis Oncology, Inc. | 1.06 | -0.03 (-2.75%) | 65.29M | D |
| 285 | MMEDF | Mind Medicine (MindMed) Inc. | 4.69 | 1.17 (33.24%) | N/A | NR |
| 286 | RLYB | Rallybio Corp | 0.67 | -0.04 (-5.12%) | 27.83M | D |
| 287 | TNYA | Tenaya Therapeutics, Inc. | 0.65 | -0.04 (-6.03%) | 56.94M | D |
| 288 | INM | InMed Pharmaceuticals Inc. | 2.47 | -0.17 (-6.46%) | 2.98M | D |
| 289 | EIGR | Eiger BioPharmaceuticals, Inc. | 1.73 | -0.18 (-9.21%) | 2.55M | NR |
| 290 | NRXP | NRx Pharmaceuticals, Inc. | 2.00 | -0.07 (-3.45%) | 33.83M | D |
| 291 | STTK | Shattuck Labs Inc. | 1.07 | -0.07 (-6.14%) | 51.08M | D |
| 292 | PSNL | Personalis, Inc. | 3.56 | -0.02 (-0.70%) | 314.22M | D |
| 293 | RGEN | Repligen Corporation | 130.71 | -6.41 (-4.67%) | 7.34B | D |
| 294 | BCDA | BioCardia, Inc. | 2.82 | 0.14 (5.22%) | 12.93M | D |
| 295 | NHWK | NightHawk Biosciences, Inc., | 0.41 | 0.03 (8.96%) | 10.78M | NR |
| 296 | VCNX | Vaccinex, Inc. | 1.00 | 0.39 (63.93%) | 2.60M | D |
| 297 | APRE | APREA THERAPEUTICS, INC. | 2.15 | -0.05 (-2.27%) | 11.81M | NR |
| 298 | NMTR | 9 Meters Biopharma, Inc. | 0.07 | -0.05 (-42.97%) | 1.04M | NR |
| 299 | SRRK | Scholar Rock Holding Corporation | 32.60 | -0.76 (-2.28%) | 3.09B | D |
| 300 | BPTS | Biophytis SA | 8.22 | -1.48 (-15.28%) | 2.89M | NR |
| 301 | BLRX | BioLineRx Ltd. | 3.11 | -0.08 (-2.51%) | 10.35M | D |
| 302 | NAUT | Nautilus Biotechnology, Inc. | 0.88 | -0.05 (-5.83%) | 111.29M | D |
| 303 | RAIN | Rain Therapeutics Inc. | 1.91 | -0.08 (-4.18%) | 14.45M | D |
| 304 | VIRI | Virios Therapeutics, Inc. | 0.16 | 0.02 (12.40%) | 2.98M | D |
| 305 | HOWL | Werewolf Therapeutics, Inc. | 1.02 | -0.05 (-4.67%) | 45.72M | D |
| 306 | CNCE | Concert Pharmaceuticals, Inc. | 8.37 | 0.01 (0.12%) | 401.24M | NR |
| 307 | VLON | Vallon Pharmaceuticals, Inc. | 0.40 | -0.06 (-13.04%) | 5.39M | NR |
| 308 | IOBT | IO Biotech, Inc. | 1.12 | -0.04 (-3.44%) | 73.79M | D |
| 309 | GRNA | GreenLight Biosciences Holdings, | 0.30 | -0.00 (-0.03%) | 45.43M | NR |
| 310 | CFRX | ContraFect Corporation | 0.05 | -0.02 (-27.95%) | 535.25K | NR |
| 311 | ENSC | Ensysce Biosciences, Inc | 3.24 | 0.12 (3.85%) | 4.55M | D |
| 312 | CYCC | Cyclacel Pharmaceuticals, Inc. | 0.30 | -0.01 (-2.75%) | 1.87M | D |
| 313 | XBIO | Xenetic Biosciences, Inc. | 3.37 | 0.11 (3.37%) | 5.20M | NR |
| 314 | LBPS | 4D pharma plc | 1.65 | 0.04 (2.48%) | 27.11M | NR |
| 315 | BLTE | Belite Bio, Inc | 66.80 | -0.05 (-0.07%) | 2.13B | D |
| 316 | UPC | Universe Pharmaceuticals INC | 4.70 | -0.66 (-12.31%) | 202.10K | D |
| 317 | INBX | Inhibrx Inc. | 14.10 | -0.22 (-1.54%) | 204.11M | D |
| 318 | ATNF | 180 Life Sciences Corp. | 1.02 | -0.01 (-0.97%) | 3.24M | D |
| 319 | CMPX | Compass Therapeutics Inc. | 2.04 | -0.06 (-3.10%) | 282.10M | D |
| 320 | ONTX | Onconova Therapeutics, Inc. | 1.00 | -0.00 (-0.47%) | 20.90M | NR |
| 321 | PRTC | PureTech Health PLC | 19.36 | 1.66 (9.38%) | 465.01M | NR |
| 322 | ANCN | Anchiano Therapeutics Ltd. - American Depositary Share | 4.71 | 0.24 (5.37%) | 34.95M | NR |
| 323 | NGM | NGM Biopharmaceuticals, Inc. | 1.54 | -0.02 (-1.28%) | 128.53M | D |
| 324 | LABP | Landos Biopharma, Inc. | 22.93 | 0.13 (0.58%) | 71.68M | D |
| 325 | ALZN | Alzamend Neuro, Inc. | 1.05 | -0.05 (-4.48%) | 6.93M | D |
| 326 | RGLS | Regulus Therapeutics Inc. | 1.58 | 0.08 (5.00%) | 104.33M | D |
| 327 | MREO | Mereo BioPharma Group plc (Mereo) | 2.36 | -0.05 (-2.07%) | 366.14M | D |
| 328 | ANPC | AnPac Bio-Medical Science Co., Ltd. | 4.37 | -0.25 (-5.41%) | 4.23M | NR |
| 329 | ORPH | Orphazyme A/S ADR | 0.87 | -0.02 (-2.25%) | 30.72M | NR |
| 330 | BLI | Berkeley Lights Inc. | 1.20 | -0.08 (-5.88%) | 86.61M | NR |
| 331 | XENE | Xenon Pharmaceuticals Inc. | 34.04 | -0.42 (-1.23%) | 2.61B | D |
| 332 | INAB | IN8bio, Inc. | 0.20 | -0.01 (-5.57%) | 15.97M | D |
| 333 | FATE | Fate Therapeutics, Inc. | 0.84 | -0.04 (-4.65%) | 96.33M | D |
| 334 | RLMD | Relmada Therapeutics, Inc. | 0.29 | -0.01 (-1.95%) | 8.82M | D |
| 335 | SWTX | SPRINGWORKS THERAPEUTICS, INC. | 47.24 | -0.25 (-0.53%) | 3.54B | D |
| 336 | HTBX | Heat Biologics, Inc. | 2.38 | 0.01 (0.42%) | 61.05M | NR |
| 337 | CBAY | CymaBay Therapeutics Inc. | 32.48 | 0.01 (0.03%) | 3.73B | D |
| 338 | COCP | Cocrystal Pharma, Inc. | 1.47 | 0.04 (2.71%) | 14.94M | NR |
| 339 | DSGN | Design Therapeutics, Inc. | 4.20 | 0.01 (0.24%) | 238.40M | D |
| 340 | BIAF | bioAffinity Technologies Inc. | 0.26 | -0.01 (-3.88%) | 4.05M | D |
| 341 | BPTH | Bio-Path Holdings, Inc. | 0.16 | -0.01 (-5.88%) | 1.33M | D |
| 342 | IPA | ImmunoPrecise Antibodies Ltd. | 0.41 | -0.04 (-8.02%) | 12.58M | D |
| 343 | CARA | Cara Therapeutics, Inc. | 5.10 | -0.28 (-5.20%) | 23.33M | D |
| 344 | AMTI | Applied Molecular Transport Inc. | 0.26 | -0.04 (-14.30%) | 10.87M | NR |
| 345 | VBIV | VBI Vaccines, Inc. - Ordinary Shares | 0.07 | -0.07 (-50.87%) | 1.87M | NR |
| 346 | COGT | Cogent Biosciences, Inc. | 6.46 | -0.15 (-2.27%) | 735.47M | D |
| 347 | TLSA | Tiziana Life Sciences plc - American Depository Share | 1.11 | -0.03 (-2.63%) | 129.70M | NR |
| 348 | CAPR | Capricor Therapeutics, Inc. | 11.17 | -0.64 (-5.46%) | 507.90M | D |
| 349 | LMNL | Liminal Biosciences Inc. | 8.50 | 0.01 (0.12%) | 26.38M | NR |
| 350 | IDRA | Idera Pharmaceuticals, Inc. | 0.43 | -0.12 (-21.57%) | 26.50M | NR |
| 351 | XLRN | Acceleron Pharma Inc. | 178.75 | -0.93 (-0.52%) | 10.93B | NR |
| 352 | ENTX | Entera Bio Ltd | 1.70 | -0.10 (-5.35%) | 60.83M | D |
| 353 | SRRA | Sierra Oncology, Inc. | 54.99 | 0.02 (0.04%) | 1.34B | NR |
| 354 | AVTE | Aerovate Therapeutics, Inc. | 2.53 | 0.00 (0.00%) | 73.33M | D |
| 355 | SAGE | Sage Therapeutics, Inc. | 8.42 | -0.24 (-2.77%) | 517.67M | D |
| 356 | UNCY | Unicycive Therapeutics, Inc., | 0.62 | -0.01 (-1.66%) | 63.94M | D |
| 357 | GNPX | Genprex, Inc. | 0.27 | -0.07 (-19.82%) | 2.33M | D |
| 358 | PAND | Pandion Therapeutics Inc. | 60.05 | 0.13 (0.22%) | 1.77B | NR |
| 359 | ICVX | Icosavax, Inc. | 15.31 | -0.14 (-0.91%) | 766.88M | D |
| 360 | MRNS | Marinus Pharmaceuticals, Inc. | 0.55 | -0.00 (-0.16%) | 30.32M | D |
| 361 | CLBS | Caladrius Biosciences, Inc. | 0.43 | -0.08 (-16.44%) | 25.83M | NR |
| 362 | ACXP | Acurx Pharmaceuticals, Inc. | 0.42 | -0.01 (-2.10%) | 9.15M | D |
| 363 | FMTX | Forma Therapeutics Holdings Inc. | 20.01 | 0.03 (0.15%) | 957.54M | NR |
| 364 | POAI | Predictive Oncology Inc. | 1.38 | -0.15 (-9.96%) | 9.43M | D |
| 365 | SABS | SAB Biotherapeutics, Inc., | 1.46 | -0.09 (-5.81%) | 13.47M | D |
| 366 | CVM | Cel-Sci Corporation | 0.24 | 0.00 (0.13%) | 19.16M | D |
| 367 | AGIO | Agios Pharmaceuticals, Inc. | 30.32 | -0.52 (-1.69%) | 1.74B | D |
| 368 | AMAM | Ambrx Biopharma Inc. | 28.00 | 0.02 (0.07%) | 1.77B | D |
| 369 | GOVX | GeoVax Labs, Inc. | 1.14 | -0.14 (-10.63%) | 10.71M | D |
| 370 | MBRX | Moleculin Biotech, Inc. | 1.04 | -0.02 (-1.43%) | 11.24M | D |
| 371 | AGTC | Applied Genetic Technologies Corporation | 0.39 | 0.00 (1.23%) | 26.62M | NR |
| 372 | KDNY | Chinook Therapeutics, Inc. | 40.39 | 0.09 (0.22%) | 2.90B | NR |
| 373 | KTRA | Kintara Therapeutics, Inc. | 0.22 | -0.01 (-6.31%) | 11.91M | NR |
| 374 | ATOS | Atossa Genetics Inc. | 0.69 | -0.01 (-1.09%) | 89.26M | D |
| 375 | CYTK | Cytokinetics, Incorporated | 42.97 | -0.03 (-0.06%) | 5.09B | D |
| 376 | CBIO | Catalyst Biosciences, Inc. | 0.51 | -0.01 (-2.65%) | 19.42M | NR |
| 377 | VTGN | VistaGen Therapeutics, Inc. | 2.60 | -0.03 (-1.14%) | 75.04M | D |
| 378 | DRTS | Alpha Tau Medical Ltd., | 2.60 | -0.06 (-2.43%) | 182.99M | D |
| 379 | BEAM | Beam Therapeutics Inc. | 22.15 | -0.04 (-0.18%) | 2.21B | D |
| 380 | BLU | BELLUS Health Inc. | 14.74 | 0.00 (0.00%) | 1.87B | NR |
| 381 | IGMS | IGM BIOSCIENCES, INC. | 1.26 | -0.03 (-1.95%) | 75.02M | D |
| 382 | EVLO | Evelo Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 9.49K | NR |
| 383 | IMPL | IMPEL NEUROPHARMA INC | 0.04 | -0.02 (-27.27%) | 956.00K | NR |
| 384 | IMV | IMV Inc. | 0.82 | -0.02 (-2.55%) | 9.63M | NR |
| 385 | XNCR | Xencor, Inc. | 11.17 | -0.34 (-2.95%) | 787.06M | D |
| 386 | GNCA | Genocea Biosciences, Inc. | 0.00 | 0.00 (0.00%) | 5.87K | NR |
| 387 | OMER | Omeros Corporation | 8.48 | -0.44 (-4.88%) | 491.42M | D |
| 388 | CELU | Celularity Inc., | 1.92 | 0.04 (2.13%) | 45.71M | D |
| 389 | FREQ | FREQUENCY THERAPEUTICS, INC. | 0.30 | 0.02 (5.94%) | 10.94M | NR |
| 390 | RAPT | RAPT THERAPEUTICS, INC. | 1.26 | -0.16 (-11.31%) | 165.67M | D |
| 391 | CRVS | Corvus Pharmaceuticals, Inc. | 3.36 | -0.01 (-0.30%) | 215.90M | D |
| 392 | SYN | Synthetic Biologics, Inc. | 1.02 | 0.01 (0.99%) | 16.16M | NR |
| 393 | TCBP | TC BioPharm (Holdings) PLC ADR | 0.50 | -1.04 (-67.53%) | 205.00K | D |
| 394 | RCKT | Rocket Pharmaceuticals, Inc. | 7.59 | -0.29 (-3.68%) | 809.32M | D |
| 395 | TSHA | Taysha Gene Therapies Inc. | 1.91 | 0.03 (1.33%) | 390.53M | D |
| 396 | VYNE | VYNE Therapeutics Inc. | 1.74 | -0.04 (-2.25%) | 26.47M | D |
| 397 | ABIO | ARCA biopharma, Inc. | 2.40 | -0.10 (-4.00%) | 34.82M | D |
| 398 | OCUL | Ocular Therapeutix, Inc. | 7.60 | -0.15 (-1.94%) | 1.21B | D |
| 399 | CATB | Catabasis Pharmaceuticals, Inc. | 8.54 | -0.64 (-6.97%) | 33.34M | NR |
| 400 | ELDN | Eledon Pharmaceuticals, Inc. | 3.35 | -0.06 (-1.76%) | 200.60M | D |
| 401 | PRME | Prime Medicine Inc. | 1.95 | -0.05 (-2.50%) | 255.76M | D |
| 402 | PEPG | PepGen Inc., | 1.49 | -0.13 (-7.76%) | 48.55M | D |
| 403 | GLYC | GlycoMimetics, Inc. | 0.22 | -0.02 (-9.54%) | 14.26M | D |
| 404 | GLMD | Galmed Pharmaceuticals Ltd. | 1.48 | -0.20 (-11.71%) | 955.18K | D |
| 405 | ABUS | Arbutus Biopharma Corporation | 3.47 | 0.20 (6.12%) | 657.54M | D |
| 406 | CNTX | Context Therapeutics Inc. | 0.70 | -0.04 (-5.44%) | 62.47M | D |
| 407 | TNXP | Tonix Pharmaceuticals Holding Corp. | 20.14 | -6.53 (-24.50%) | 37.64M | D |
| 408 | IOVA | Iovance Biotherapeutics, Inc. | 3.59 | -0.04 (-1.10%) | 1.18B | D |
| 409 | TTNP | Titan Pharmaceuticals, Inc. | 3.76 | -0.11 (-2.97%) | 3.44M | NR |
| 410 | INO | Inovio Pharmaceuticals Inc. | 1.72 | -0.04 (-2.27%) | 44.89M | D |
| 411 | IMGO | Imago BioSciences, Inc. | 36.01 | 0.01 (0.03%) | 1.22B | NR |
| 412 | AIKI | AIkido Pharma Inc. | 3.56 | 0.01 (0.28%) | 19.53M | NR |
| 413 | UBX | Unity Biotechnology, Inc. | 1.11 | -0.07 (-5.93%) | 18.72M | D |
| 414 | FPRX | Five Prime Therapeutics, Inc. | 38.00 | 0.01 (0.03%) | 1.77B | NR |
| 415 | NCNA | NuCana plc - American Depositary Share | 1.10 | 0.03 (2.34%) | 2.89M | D |
| 416 | FWP | Forward Pharma A/S | 1.95 | 0.14 (7.73%) | 13.83M | NR |
| 417 | AYLA | Ayala Pharmaceuticals Inc. | 0.50 | 0.03 (5.84%) | 7.46M | NR |
| 418 | IFRX | InflaRx N.V. | 1.22 | -0.04 (-2.80%) | 81.57M | D |
| 419 | INZY | Inozyme Pharma Inc. | 0.95 | -0.05 (-4.90%) | 60.77M | D |
| 420 | KZIA | Kazia Therapeutics Limited | 0.94 | -0.02 (-1.58%) | 4.71M | D |
| 421 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. Common Shares | 27.27 | -1.12 (-3.95%) | 2.78B | D |
| 422 | OYST | OYSTER POINT PHARMA, INC. | 11.17 | 0.02 (0.18%) | 299.85M | NR |
| 423 | VAXX | Vaxxinity, Inc. | 0.01 | -0.03 (-85.71%) | 633.74K | D |
| 424 | PRQR | ProQR Therapeutics N.V. - Ordinary Shares | 1.41 | -0.03 (-1.75%) | 147.82M | D |
| 425 | MNPR | MONOPAR THERAPEUTICS | 39.26 | -2.13 (-5.15%) | 239.56M | D |
| 426 | CGTX | Cognition Therapeutics | 0.42 | -0.03 (-7.68%) | 17.29M | D |
| 427 | APDN | Applied DNA Sciences Inc | 1.86 | -0.01 (-0.64%) | 2.05M | D |
| 428 | AEZS | Aeterna Zentaris Inc. | 5.72 | 0.32 (5.93%) | 10.26M | NR |
| 429 | SLDB | Solid Biosciences Inc. | 4.28 | -0.09 (-2.17%) | 331.67M | D |
| 430 | EDIT | Editas Medicine, Inc. | 1.26 | -0.05 (-3.46%) | 104.13M | D |
| 431 | PALI | Palisade Bio Inc. | 0.70 | 0.01 (1.38%) | 1.93M | D |
| 432 | VTYX | Ventyx Biosciences, Inc. | 1.21 | -0.02 (-1.63%) | 86.07M | D |
| 433 | OTLK | Outlook Therapeutics, Inc. | 1.34 | -0.06 (-4.29%) | 42.90M | D |
| 434 | MRUS | Merus N.V. | 44.24 | -0.59 (-1.32%) | 3.06B | D |
| 435 | KDMN | Kadmon Holdings, Inc. | 9.50 | 0.02 (0.21%) | 1.70B | NR |
| 436 | IMMP | Immutep Limited | 1.82 | 0.00 (0.00%) | 264.92M | D |
| 437 | EQRX | EQRx, Inc. | 2.34 | -0.05 (-2.09%) | 1.14B | NR |
| 438 | NNVC | NanoViricides, Inc. NEW | 1.19 | -0.02 (-1.65%) | 18.61M | D |
| 439 | CGEM | Cullinan Oncology Inc. | 8.18 | -0.11 (-1.33%) | 478.64M | D |
| 440 | MTP | Midatech Pharma PLC | 0.29 | -0.06 (-18.52%) | 6.18M | NR |
| 441 | RNAZ | TransCode Therapeutics, Inc., | 0.58 | 0.06 (10.73%) | 400.76K | D |
| 442 | IMNM | Immunome Inc. | 6.97 | -0.31 (-4.26%) | 606.05M | D |
| 443 | CLXT | Calyxt, Inc. | 6.30 | 0.33 (5.53%) | 31.34M | NR |
| 444 | MRVI | Maravai LifeSciences | 2.35 | 0.00 (-0.21%) | 593.44M | D |
| 445 | EFTR | eFFECTOR Therapeutics, Inc. | 0.00 | 0.00 (0.00%) | 0.94K | D |
| 446 | ONCY | Oncolytics Biotech Inc. | 0.60 | -0.01 (-2.31%) | 51.85M | D |
| 447 | TCRR | TCR2 Therapeutics Inc. | 1.48 | -0.09 (-5.73%) | 58.11M | NR |
| 448 | CLNN | Clene Inc. | 3.19 | 0.01 (0.32%) | 27.39M | D |
| 449 | REVB | Revelation Biosciences, Inc., | 2.76 | 0.00 (-0.18%) | 2.50M | D |
| 450 | OMGA | Omega Therapeutics, Inc. | 0.14 | -0.02 (-10.82%) | 7.90M | D |
| 451 | EDSA | Edesa Biotech, Inc. | 2.48 | -0.05 (-1.98%) | 17.34M | D |
| 452 | CBLI | Cleveland BioLabs, Inc. | 3.17 | -0.25 (-7.31%) | 49.07M | NR |
| 453 | AGE | AgeX Therapeutics, Inc. | 11.10 | -1.50 (-11.90%) | 11.97M | NR |
| 454 | NWBO | Northwest Bioth Cmn | 0.24 | -0.00 (-0.54%) | 330.09M | D |
| 455 | AVXL | Anavex Life Sciences Corp. | 8.87 | -0.67 (-7.02%) | 754.52M | D |
| 456 | GRTS | Gritstone Oncology, Inc. | 0.03 | -0.02 (-31.78%) | 3.50M | D |
| 457 | TRVN | Trevena, Inc. | 1.25 | -0.04 (-2.89%) | 1.08M | D |
| 458 | CCCC | C4 Therapeutics Inc. | 1.77 | -0.08 (-4.08%) | 125.30M | D |
| 459 | AGLE | Aeglea BioTherapeutics, Inc. | 12.01 | 0.97 (8.79%) | 48.63M | NR |
| 460 | EVFM | Evofem Biosciences, Inc. | 0.01 | 0.00 (0.00%) | 1.11M | NR |
| 461 | PHIO | Phio Pharmaceuticals Corp | 1.27 | -0.04 (-3.05%) | 8.75M | D |
| 462 | GERN | Geron Corporation | 1.62 | -0.04 (-2.12%) | 1.03B | D |
| 463 | PHAT | PHATHOM PHARMACEUTICALS, INC. | 6.51 | -0.18 (-2.69%) | 453.34M | D |
| 464 | DRMA | Dermata Therapeutics, Inc. | 1.23 | -0.19 (-13.30%) | 2.51M | D |
| 465 | CWBR | CohBar, Inc. | 0.41 | 0.00 (0.00%) | 1.19M | NR |
| 466 | CADL | Candel Therapeutics, Inc. | 6.11 | -0.84 (-12.01%) | 288.61M | D |
| 467 | ELEV | Elevation Oncology, Inc. | 0.26 | 0.00 (1.04%) | 15.56M | D |
| 468 | BNOX | Bionomics Limited, | 0.25 | 0.01 (4.20%) | 4.47M | D |
| 469 | INKT | MiNK Therapeutics, Inc. | 9.23 | 0.73 (8.53%) | 36.61M | NR |
| 470 | LBPH | Longboard Pharmaceuticals, Inc., | 59.98 | 0.02 (0.03%) | 2.34B | D |
| 471 | TMBR | Timber Pharmaceuticals, Inc. | 0.35 | 0.01 (3.09%) | 1.21M | NR |
| 472 | IMUX | Immunic, Inc. | 1.19 | -0.06 (-4.44%) | 106.74M | D |
| 473 | VIE | VIELA BIO, INC. | 53.01 | 0.00 (0.00%) | 2.91B | NR |
| 474 | BLCM | Bellicum Pharmaceuticals, Inc. | 0.07 | -0.01 (-6.62%) | 726.83K | NR |
| 475 | PTN | Palatin Technologies, Inc. | 0.65 | -0.05 (-7.27%) | 16.88M | D |
| 476 | BCYC | Bicycle Therapeutics plc | 9.00 | -0.19 (-2.07%) | 622.82M | D |
| 477 | MORF | Morphic Holding, Inc. | 56.99 | 0.02 (0.04%) | 2.85B | D |
| 478 | PLXP | PLx Pharma, Inc. | 0.02 | 0.00 (0.00%) | 603.16K | NR |
| 479 | BIVI | BioVie Inc. | 1.02 | -0.07 (-6.02%) | 18.73M | D |
| 480 | ONCR | Oncorus Inc. | 0.13 | -0.00 (-3.08%) | 3.29M | NR |
| 481 | PRPO | Precipio, Inc. | 6.27 | 0.01 (0.15%) | 9.29M | NR |
| 482 | QURE | uniQure N.V. - Ordinary Shares | 12.21 | -0.91 (-6.97%) | 660.28M | D |
| 483 | CLGN | CollPlant Biotechnologies Ltd. | 2.57 | -0.08 (-3.02%) | 29.44M | NR |
| 484 | CERE | Ceres Inc | 44.96 | 0.33 (0.74%) | 8.19B | NR |
| 485 | MNMD | Mind Medicine (MindMed) Inc. | 6.22 | -0.21 (-3.27%) | 468.79M | D |
| 486 | AKRO | Akero Therapeutics, Inc. | 42.76 | -0.83 (-1.89%) | 3.40B | D |
| 487 | ENVB | Enveric Biosciences Inc. | 1.42 | -0.18 (-11.25%) | 962.76K | D |
| 488 | TYRA | Tyra Biosciences, Inc. | 9.91 | 0.26 (2.64%) | 501.48M | D |
| 489 | HEPA | Hepion Pharmaceuticals, Inc. | 0.54 | -0.07 (-11.64%) | 74.92K | D |
| 490 | BNGO | Bionano Genomics, Inc. | 2.85 | -0.22 (-7.02%) | 7.79M | D |
| 491 | AMPE | Ampio Pharmaceuticals, Inc. | 0.00 | -0.00 (-71.43%) | 0.68K | D |
| 492 | ALRN | Aileron Therapeutics, Inc. | 2.11 | 0.18 (9.33%) | 45.72M | D |
| 493 | EWTX | Edgewise Therapeutics, Inc. | 23.10 | -0.34 (-1.45%) | 2.20B | D |
| 494 | CRTX | Cortexyme, Inc. | 1.95 | 0.05 (2.63%) | 58.79M | NR |
| 495 | XFOR | X4 Pharmaceuticals, Inc. | 0.27 | -0.00 (-1.55%) | 46.35M | D |
| 496 | EARS | Auris Medical Holding Ltd. | 3.05 | -0.05 (-1.77%) | 34.82M | NR |
| 497 | ZIOP | ZIOPHARM Oncology Inc | 0.87 | -0.01 (-0.88%) | 187.12M | NR |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 1.41 | 0.11 (8.46%) | 12.12M | D |
| 499 | SLS | SELLAS Life Sciences Group, Inc. | 1.12 | -0.04 (-3.45%) | 78.83M | D |
| 500 | ADGI | Adagio Therapeutics, Inc. | 4.64 | 0.04 (0.87%) | 504.98M | NR |
| 501 | INSM | Insmed, Inc. | 77.26 | -0.43 (-0.55%) | 13.98B | D |
| 502 | ARTL | Artelo Biosciences, Inc. | 0.95 | -0.02 (-1.55%) | 3.12M | NR |
| 503 | GLTO | Galecto Inc. | 3.39 | -0.04 (-1.17%) | 4.48M | D |
| 504 | ORIC | Oric Pharmaceuticals Inc. | 6.16 | -0.13 (-1.99%) | 437.53M | D |
| 505 | CERC | Cerecor Inc. | 2.93 | -0.05 (-1.68%) | 281.31M | NR |
| 506 | ALPN | Alpine Immune Sciences, Inc. | 64.97 | 0.01 (0.02%) | 4.46B | D |
| 507 | ADTX | ADiTx Therapeutics Inc. | 4.95 | -1.22 (-19.79%) | 282.15K | D |
| 508 | LTRN | Lantern Pharma Inc. | 3.53 | -0.19 (-5.11%) | 38.07M | D |
| 509 | ALDX | Aldeyra Therapeutics, Inc. | 6.37 | 0.11 (1.76%) | 380.35M | D |
| 510 | NDRA | ENDRA Life Sciences Inc. | 4.30 | 0.05 (1.18%) | 2.31M | D |
| 511 | PMVP | PMV Pharmaceuticals Inc. | 1.14 | -0.01 (-0.87%) | 59.20M | D |
| 512 | LGVN | Longeveron Inc. | 1.57 | -0.13 (-7.40%) | 23.50M | D |
| 513 | ENOB | Enochian Biosciences, Inc. | 0.70 | 0.00 (0.00%) | 40.80M | NR |
| 514 | PPBT | Purple Biotech Ltd | 2.75 | -0.01 (-0.19%) | 3.66M | D |
| 515 | AIM | AIM ImmunoTech Inc. | 0.12 | -0.01 (-5.86%) | 8.28M | NR |
| 516 | DYN | Dyne Therapeutics, Inc. | 11.43 | -0.37 (-3.14%) | 1.29B | D |
| 517 | NTLA | Intellia Therapeutics, Inc. | 8.15 | -0.25 (-3.04%) | 843.66M | D |
| 518 | NAVB | Navidea Biopharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | 40.03K | NR |
| 519 | FBRX | Forte Biosciences, Inc. | 7.10 | -0.81 (-10.24%) | 45.39M | D |
| 520 | LIPO | Lipella Pharmaceuticals Inc. | 2.57 | -0.15 (-5.51%) | 3.11M | D |
| 521 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 1.01 | -0.09 (-7.80%) | 33.61M | D |
| 522 | SNCA | Seneca Biopharma, Inc. | 1.66 | -0.02 (-1.19%) | 28.71M | NR |
| 523 | ORMP | Oramed Pharmaceuticals Inc. | 2.21 | -0.09 (-3.91%) | 89.09M | D |
| 524 | OKYO | OKYO Pharma Limited, | 1.36 | -0.07 (-4.90%) | 46.02M | D |
| 525 | KOD | Kodiak Sciences Inc | 2.90 | -0.16 (-5.23%) | 152.61M | D |
| 526 | XBIT | XBiotech Inc. | 3.13 | -0.11 (-3.40%) | 95.43M | D |
| 527 | AUTL | Autolus Therapeutics plc - American Depositary Share | 1.69 | 0.04 (2.42%) | 449.70M | D |
| 528 | BLUE | bluebird bio, Inc. | 3.78 | -0.01 (-0.26%) | 36.75M | D |
| 529 | NBTX | Nanobiotix S.A. ADR | 3.61 | 0.05 (1.40%) | 170.15M | NR |
| 530 | PRVB | Provention Bio, Inc. | 24.98 | 0.75 (3.10%) | 2.37B | NR |
| 531 | SIOX | Sio Gene Therapies, Inc. | 0.48 | 0.01 (1.70%) | 34.87M | NR |
| 532 | PHVS | Pharvaris N.V. | 15.80 | 0.23 (1.48%) | 826.18M | D |
| 533 | AFMD | Affimed N.V. | 0.78 | -0.02 (-2.94%) | 12.58M | D |
| 534 | SMFR | Sema4 Holdings Corp. | 0.31 | 0.07 (26.78%) | 117.17M | NR |
| 535 | OGEN | Oragenics Inc. | 0.22 | -0.02 (-8.03%) | 4.62M | D |
| 536 | FBIO | Fortress Biotech, Inc. | 1.61 | -0.12 (-6.94%) | 44.44M | D |
| 537 | ARPO | Aerpio Pharmaceuticals, Inc. | 2.20 | -0.02 (-0.90%) | 104.85M | NR |
| 538 | ANNX | Annexon Inc. | 2.27 | 0.03 (1.12%) | 249.04M | D |
| 539 | OLMA | Olema Pharmaceuticals | 4.04 | -0.16 (-3.81%) | 276.07M | D |
| 540 | ATNM | Actinium Pharmaceuticals, Inc. (Delaware) | 1.83 | -0.07 (-3.44%) | 56.93M | D |
| 541 | KLDO | Kaleido Biosciences, Inc. | 0.00 | -0.00 (-90.00%) | 4.26K | NR |
| 542 | TPTX | Turning Point Therapeutics, Inc. - Common stock | 76.01 | 0.52 (0.69%) | 3.81B | NR |
| 543 | THRD | Third Harmonic Bio Inc. | 3.52 | 0.03 (0.86%) | 158.60M | D |
| 544 | APVO | Aptevo Therapeutics Inc. | 1.14 | -0.11 (-8.80%) | 1.66M | D |
| 545 | BTTX | Better Therapeutics, Inc. | 0.00 | 0.00 (0.00%) | 14.96K | NR |
| 546 | PDSB | PDS Biotechnology Corporation | 1.27 | 0.02 (1.60%) | 48.51M | D |
| 547 | CLRB | Cellectar Biosciences, Inc. | 0.33 | -0.03 (-7.38%) | 15.37M | D |
| 548 | QLGN | Qualigen Therapeutics Inc | 3.34 | -0.44 (-11.64%) | 2.46M | D |
| 549 | ADVM | Adverum Biotechnologies, Inc. | 4.69 | -0.27 (-5.45%) | 97.56M | D |
| 550 | GALT | Galectin Therapeutics Inc. | 1.60 | -0.08 (-4.76%) | 100.42M | D |
| 551 | LXXGF | Lexagene Holdings Inc. | 0.08 | -0.02 (-16.48%) | N/A | NR |
| 552 | SAVA | Cassava Sciences, Inc. | 1.68 | -0.03 (-1.47%) | 80.92M | D |
| 553 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 1.27 | -0.04 (-3.05%) | 3.89M | D |
| 554 | NURO | NeuroMetrix, Inc. | 4.42 | -0.09 (-2.10%) | 9.11M | D |
| 555 | RVMD | Revolution Medicines Inc. | 37.62 | -0.48 (-1.26%) | 6.99B | D |
| 556 | CRSP | CRISPR Therapeutics AG | 37.29 | -0.75 (-1.97%) | 3.20B | D |
| 557 | MDWD | MediWound Ltd. - Ordinary Shares | 16.10 | -0.88 (-5.18%) | 173.77M | D |
| 558 | ACHV | Achieve Life Sciences, Inc. | 2.78 | -0.12 (-4.14%) | 96.42M | D |
| 559 | MRNA | Moderna Inc. | 31.30 | -0.82 (-2.55%) | 12.10B | D |
| 560 | PROG | Progenity Inc. | 0.88 | -0.03 (-3.47%) | 162.92M | NR |
| 561 | GNLX | Genelux Corp. | 3.13 | 0.10 (3.30%) | 108.70M | D |
| 562 | NUVL | Nuvalent, Inc. | 73.22 | -0.40 (-0.54%) | 5.24B | D |
| 563 | ABOS | Acumen Pharmaceuticals, Inc. | 1.16 | -0.08 (-6.10%) | 69.39M | D |
| 564 | CVKD | Cadrenal Therapeutics Inc. | 18.15 | -0.56 (-2.99%) | 34.12M | D |
| 565 | KROS | Keros Therapeutics Inc. | 10.73 | -0.26 (-2.37%) | 435.23M | D |
| 566 | ACRV | Acrivon Therapeutics Inc. | 2.26 | -0.26 (-10.32%) | 70.37M | D |
| 567 | GANX | Gain Therapeutics, Inc. | 1.94 | -0.13 (-6.28%) | 51.46M | D |
| 568 | AKTX | Akari Therapeutics Plc | 1.30 | -0.01 (-0.41%) | 34.57M | NR |
| 569 | NVIV | InVivo Therapeutics Holdings Corp. | 0.32 | -0.17 (-34.28%) | 995.77K | NR |
| 570 | MBIO | Mustang Bio, Inc. | 1.33 | -0.09 (-6.03%) | 1.28M | D |
| 571 | GMDA | Gamida Cell Ltd. - Ordinary Shares | 0.03 | -0.01 (-18.25%) | 5.04M | NR |
| 572 | KRBP | Kiromic Biopharma Inc. | 0.16 | -0.15 (-48.74%) | 251.52K | NR |
| 573 | IMVT | Immunovant, Inc. | 18.19 | -0.60 (-3.19%) | 3.09B | D |
| 574 | VLNCF | The Valens Company Inc. | 1.41 | -0.12 (-7.90%) | N/A | NR |
| 575 | MRTX | Mirati Therapeutics, Inc. | 58.70 | -0.10 (-0.17%) | 4.12B | NR |
| 576 | CYBN | Cybin Inc. | 6.73 | -0.29 (-4.13%) | 144.54M | D |
| 577 | TFFP | TFF PHARMACEUTICALS, INC. | 0.07 | -0.10 (-60.05%) | 288.80K | D |
| 578 | ARWR | Arrowhead Pharmaceuticals, Inc. | 13.82 | 0.02 (0.18%) | 1.90B | D |
| 579 | EXAI | Exscientia Holdings Limited | 4.84 | 0.15 (3.20%) | 632.93M | D |
| 580 | VINC | Vincerx Pharma, Inc. | 0.54 | -0.03 (-5.44%) | 1.20M | D |
| 581 | LIFE | aTyr Pharma, Inc. | 1.90 | 0.05 (2.70%) | 131.12M | D |
| 582 | FDMT | 4D Molecular Therapeutics Inc. | 3.56 | 0.00 (-0.14%) | 164.84M | D |
| 583 | DYAI | Dyadic International, Inc. | 1.34 | -0.01 (-0.47%) | 39.76M | D |
| 584 | IKT | Inhibikase Therapeutics Inc. | 2.22 | -0.15 (-6.33%) | 153.98M | D |
| 585 | ISEE | IVERIC bio, Inc. | 39.95 | 0.15 (0.38%) | 5.50B | NR |
| 586 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 5.57 | -0.22 (-3.89%) | 68.13M | D |
| 587 | AZRX | AzurRx BioPharma, Inc. | 3.45 | 0.07 (2.07%) | 32.17M | NR |
| 588 | APTO | Aptose Biosciences, Inc. | 3.36 | -0.34 (-9.19%) | 7.19M | D |
| 589 | AXLA | Axcella Health Inc. | 0.40 | -0.04 (-8.89%) | 1.18M | NR |
| 590 | XCUR | Exicure, Inc. | 13.94 | -0.06 (-0.43%) | 36.33M | D |
| 591 | CRBU | Caribou Biosciences, Inc. | 0.94 | -0.05 (-4.95%) | 87.41M | D |
| 592 | VERA | Vera Therapeutics, Inc. | 26.23 | -0.29 (-1.09%) | 1.67B | D |
| 593 | CYDY | CytoDyn Inc. | 0.23 | -0.00 (-1.88%) | 289.01M | NR |
| 594 | KTTA | Pasithea Therapeutics Corp. | 1.30 | -0.02 (-1.39%) | 1.65M | NR |
| 595 | PLRX | Pliant Therapeutics Inc. | 1.52 | 0.01 (0.33%) | 92.77M | D |
| 596 | CRDF | Cardiff Oncology, Inc. | 3.29 | -0.15 (-4.51%) | 218.86M | D |
| 597 | IBIO | iBio, Inc. | 4.15 | -0.26 (-5.90%) | 40.98M | D |
| 598 | NUVB | Nuvation Bio Inc. | 1.85 | -0.02 (-1.07%) | 626.56M | D |
| 599 | ABSI | AbSci Corp | 2.71 | -0.10 (-3.38%) | 345.08M | D |
| 600 | LXRX | Lexicon Pharmaceuticals, Inc. | 0.63 | 0.28 (80.96%) | 154.88M | D |
| 601 | DICE | DICE Therapeutics, Inc. | 47.55 | 0.03 (0.06%) | 2.27B | NR |
| 602 | IMRX | Immuneering Corp | 1.61 | -0.05 (-3.01%) | 57.78M | F |
| 603 | ZSAN | Zosano Pharma Corporation | 0.56 | 0.04 (7.23%) | 2.73M | NR |
| 604 | RANI | Rani Therapeutics Holdings, Inc. | 1.35 | 0.01 (0.99%) | 77.52M | F |
| 605 | PRPH | ProPhase Labs, Inc. | 0.39 | -0.07 (-15.67%) | 9.26M | F |
| 606 | ATAI | ATAI Life Sciences N.V. | 1.48 | -0.09 (-5.73%) | 293.49M | F |
| 607 | LRMR | Larimar Therapeutics, Inc. | 2.32 | -0.08 (-3.33%) | 148.54M | F |
| 608 | SLNO | Soleno Therapeutics, Inc. | 73.07 | 5.68 (8.43%) | 3.35B | F |
| 609 | BXRX | Baudax Bio, Inc. | 0.02 | 0.00 (7.39%) | 1.14M | NR |
| 610 | SANA | Sana Biotechnology, Inc. | 1.72 | -0.13 (-7.05%) | 385.92M | F |
| 611 | TBIO | Translate Bio, Inc. | 0.29 | 0.00 (0.00%) | 522.58K | F |
| 612 | CDTX | Cidara Therapeutics, Inc. | 22.19 | 0.61 (2.83%) | 243.05M | F |
| 613 | KYMR | Kymera Therapeutics Inc. | 30.00 | -0.20 (-0.66%) | 1.95B | F |
| 614 | PRAX | Praxis Precision Medicines Inc. | 39.15 | 0.31 (0.79%) | 789.38M | F |
| 615 | CDXS | Codexis, Inc. | 2.81 | -0.12 (-3.94%) | 232.77M | F |
| 616 | KRTX | Karuna Therapeutics, Inc. | 329.83 | 0.09 (0.03%) | 12.58B | NR |
| 617 | NKTX | Nkarta Inc. | 2.03 | 0.06 (3.05%) | 143.26M | F |
| 618 | VRPX | Virpax Pharmaceuticals, Inc. | 1.36 | -0.12 (-8.11%) | 1.69M | F |
| 619 | CMRA | Comera Life Sciences Holdings, Inc. | 0.00 | 0.00 (0.00%) | 6.15K | NR |
| 620 | LPTX | Leap Therapeutics, Inc. | 0.33 | -0.04 (-10.91%) | 12.45M | F |
| 621 | ABVC | ABVC BioPharma, Inc. | 0.85 | 0.05 (5.88%) | 10.98M | F |
| 622 | OCGN | Ocugen Inc. | 0.75 | 0.02 (3.09%) | 217.93M | F |
| 623 | AKER | Akers Biosciences Inc. | 2.47 | -0.26 (-9.52%) | 41.13M | NR |
| 624 | NRIX | Nurix Therapeutics Inc. | 12.20 | -0.35 (-2.79%) | 925.82M | F |
| 625 | PGEN | Precigen, Inc. | 1.59 | -0.06 (-3.35%) | 466.06M | F |
| 626 | MLTX | MoonLake Immunotherapeutics, | 39.83 | -0.01 (-0.03%) | 2.55B | F |
| 627 | AGFY | Agrify Corporation | 20.07 | -1.07 (-5.04%) | 30.71M | F |
| 628 | ABCL | AbCellera Biologics Inc. | 2.30 | -0.06 (-2.75%) | 685.37M | F |
| 629 | TYHT | Shineco, Inc. | 11.09 | -0.45 (-3.90%) | 97.24M | NR |
| 630 | CBUS | Cibus Inc. | 1.99 | -0.05 (-2.45%) | 64.95M | F |
| 631 | ETNB | 89BIO, INC. | 8.18 | -0.78 (-8.71%) | 1.19B | F |
| 632 | JSPR | Jasper Therapeutics, Inc., | 4.45 | -0.39 (-8.16%) | 66.85M | F |
| 633 | ALT | Altimmune, Inc. | 5.37 | -0.20 (-3.59%) | 413.57M | F |
| 634 | CABA | CABALETTA BIO, INC. | 1.52 | -0.09 (-5.59%) | 74.29M | F |
| 635 | RNA | Avidity Biosciences Inc. | 31.79 | -0.77 (-2.36%) | 3.82B | F |
| 636 | BFRG | Bullfrog AI Holdings Inc. | 1.69 | -0.12 (-6.63%) | 15.91M | F |
| 637 | QSI | Quantum-Si incorporated | 1.27 | -0.04 (-3.05%) | 232.59M | F |
| 638 | INMB | INmune Bio Inc. - Common stock | 7.52 | 0.11 (1.48%) | 199.96M | F |
| 639 | HUMA | Humacyte, Inc. | 1.87 | -0.14 (-7.21%) | 235.36M | F |
| 640 | CLDX | Celldex Therapeutics Inc. | 19.83 | -0.15 (-0.73%) | 1.32B | F |
| NR | ANACU | Anacor Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | RVVTF | Revive Therapeutics Ltd. | 0.01 | 0.00 (25.00%) | N/A | NR |
| NR | RCOR | Renovacor, Inc., | 3.20 | 0.15 (4.92%) | 55.26M | NR |
| NR | VLNS | Valens Co. Inc. | 0.76 | 0.00 (0.03%) | 61.38M | NR |
| NR | RSCF | Reflect Scientific Inc. | 0.05 | -0.00 (-8.13%) | N/A | NR |
| NR | ANTH | Anthera Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | SPHS | Sophiris Bio, Inc. | 0.00 | 0.00 (0.00%) | 3.56K | NR |
| NR | ENZN | Enzon Pharmaceuticals | 0.11 | 0.01 (5.87%) | 8.16M | NR |
| NR | CYAD | Celyad SA | 0.47 | -0.06 (-11.10%) | 10.62M | NR |
| NR | AMRH | Enveric Biosciences Inc. | 1.48 | -0.22 (-12.94%) | 11.09M | NR |
| NR | PHGE | BiomX Inc. | 0.55 | -0.01 (-1.68%) | 13.75M | NR |
| NR | NVUS | Eledon Pharmaceuticals, Inc. | 14.60 | -0.80 (-5.19%) | 20.97M | NR |
| NR | KMPHD | KemPharm, Inc. | 8.25 | -1.06 (-11.39%) | 35.60M | NR |
| NR | ICCC | ImmuCell Corporation | 5.04 | 0.14 (2.78%) | 44.92M | NR |
| NR | MGEN | Miragen Therapeutics, Inc. | 23.01 | -0.02 (-0.09%) | 89.92M | NR |
| NR | XYNO | Xynomic Pharmaceuticals Holdings, Inc. | 2.22 | 0.06 (2.78%) | 102.73M | NR |
| NR | PDLI | PDL BioPharma, Inc. | 2.47 | -0.23 (-8.52%) | 282.14M | NR |
| NR | HQL | Tekla Life Sciences Investors | 12.88 | -0.10 (-0.77%) | 352.28M | NR |
| NR | OPT | Opthea Ltd. ADR | 3.41 | 0.23 (7.23%) | 524.84M | NR |
| NR | PHAR | Pharming Group NV | 8.72 | 0.07 (0.81%) | 593.23M | NR |
| NR | PRVL | Prevail Therapeutics Inc. - common stock | 23.00 | -0.02 (-0.09%) | 787.66M | NR |
All price changes on this page include dividends and splits.